MercoPress, en Español

Montevideo, October 22nd 2021 - 04:20 UTC

 

 

Argentina's regulator approves the AstraZeneca and Oxford University Covid-19 vaccine

Thursday, December 31st 2020 - 08:50 UTC
Full article 12 comments
Argentina has a contract to buy 22.4 million doses of the AstraZeneca/Oxford vaccine, which the company said would all be delivered in 2021 Argentina has a contract to buy 22.4 million doses of the AstraZeneca/Oxford vaccine, which the company said would all be delivered in 2021
AstraZeneca said the approval by ANMAT made Argentina “one of the first countries in the world to authorize” the drug, after the UK regulator gave the green light on Wednesday AstraZeneca said the approval by ANMAT made Argentina “one of the first countries in the world to authorize” the drug, after the UK regulator gave the green light on Wednesday

Argentina's regulator on Wednesday approved the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use, AstraZeneca said in a statement.

AstraZeneca said the approval by the National Administrator for Food and Medical Technology (ANMAT) made Argentina “one of the first countries in the world to authorize” the drug, after the UK regulator gave the green light for its widespread roll-out earlier on Wednesday.

The company said the approval was for the vaccine to be administered to people over the age of 18 in two doses between four and 12 weeks apart, as per the UK approval.

Argentina has a contract to buy 22.4 million doses of the AstraZeneca/Oxford vaccine, which the company said would all be delivered in 2021. Argentina's President Alberto Fernandez said in August that Argentina and Mexico would also work together to produce the AstraZeneca vaccine for most of Latin America.

Agustín Lamas, President of AstraZeneca in Latin America's Southern Cone, said: “A new stage in this process begins, we feel hopeful and confident in achieving what we set out to do from the beginning: broad and equitable access, without profit for the duration of the pandemic.”

The Argentine regulator said in a statement that it had judged the vaccine's emergency roll-out to present “an acceptable benefit-risk balance.”

Argentina on Christmas Eve began vaccinating health workers using 300,000 doses of the Russian Sputnik V vaccine.

Argentina is preparing for a potential second wave facing other countries in the region including Chile, Mexico and Brazil. It has so far registered 1,602,163 cases of COVID-19 and 43,018 deaths.

Top Comments

Disclaimer & comment rules
  • Dirk Dikkler

    From the UK to Argentina “YOUR WELCOME”, this is what GOOD Neighbours do !!!

    Dec 31st, 2020 - 05:42 pm 0
  • Brit Bob

    Recent conclusions of the results of the inoculation of the English Oxford vaccine in Argentine volunteers reveal that those who received placebo continue to claim the Argentine sovereignty of the Malvinas, the group that received the British Antivirus now calls them Falklands

    Jan 01st, 2021 - 11:31 am 0
  • Think

    Geeeeee....

    - This Anglo Turnips always brighten me day with their Basil Fawlty kind of Turnipidity...:-)

    -A vaccine being produced in Argentina..., developed, patented and owned by a Swedish Company, directed by a French CEO..., and they Think..., it must be Brutish... :-))

    Speaking about Brutish and Frogs...
    Well done..., Monsieur Stanley Johnson..., Bienvenue...:-)))

    Capisce...?

    Jan 01st, 2021 - 01:11 pm 0
Read all comments

Commenting for this story is now closed.
If you have a Facebook account, become a fan and comment on our Facebook Page!